Clinical Trials Logo

Clinical Trial Summary

This prospective multi-site observational study aims to describe causes and clinical outcomes of acute febrile illness as well as host biomarkers in patients aged >28 days residing in rural areas in Laos, Myanmar, Thailand, the Thai-Myanmar border region, and Bangladesh and presenting with acute febrile illnesses (≤ 14 days duration) to participating health facilities. This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z


Clinical Trial Description

The majority of people in low- and middle-income countries (LMICs) in South and Southeast Asia live in rural areas. These people are some of the poorest in the region and the exact health issues which concern them have not been well defined, in that they have not been fully studied. Despite this lack of data, there are indications that disease of an infectious aetiology, 'febrile illness,' in particular in the tropics, still accounts for significant morbidity and mortality. This is in contrast to higher-income countries. The South and Southeast Asian Community-based Trials Network in Rural Febrile Illness project (SEACTN RFI) aims to better understand and quantify the burden of febrile illness, the aetiological causes and the manner in which it affects the people of the area, all on a scale which has not been attempted before. It will collect information to help better understand and predict these outcomes based on a multitude of factors, which will form the basis for interventions within the network in the future. The initial study will be observational, as the current understanding of the local health issues and the health systems in these areas is insufficient to know how best to intervene. In a separate work package, Work Package A (WP-A), the investigators will be collecting data from within the participating SEACTN communities through village health workers (VHWs) and local health facilities on the incidence, causes and outcomes of febrile illness in these areas. In Work Package B (WP-B) will recruit patients seeking care at higher level facilities than the WP-A VHWs and health centres. These patients are likely to be more severely ill, in order to obtain a more thorough understanding of the causes and burden of febrile illness in these areas. A broader range of specimens, including venous blood samples and respiratory specimens will be collected. In-depth diagnostic testing including blood cultures, serological assays, pathogen molecular diagnostics, host biomarker assays, and validation of pathogen-blind next generation sequencing approaches will be conducted. The data from WP-A gathered in the community complemented by the WP-B data from higher level health facilities in the same regions will provide a rich understanding of the causes, incidence and outcomes of febrile illness in these areas. These data will be analysed using advanced statistical methodology to create electronic decision-support tools (eDSTs) to aid VHWs in their assessment, triage and treatment of patients. These and other relevant interventions will later be trialled across the SEACTN villages. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04629053
Study type Observational
Source University of Oxford
Contact Yoel Lubell, Prof.
Phone +66-857201350
Email yoel@tropmedres.ac
Status Recruiting
Phase
Start date June 21, 2022
Completion date December 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT03943654 - Improving Nighttime Access to Care and Treatment (Part 2)
Completed NCT04299412 - Diagnostic Accuracy of the DPP II Assay
Completed NCT04299607 - Evaluation of the DPP II Assay in Laos
Recruiting NCT05050825 - Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal N/A
Recruiting NCT04878549 - Transcriptomic Responses for the Identification of Pathogens
Completed NCT04268732 - Acute Undifferentiated Fever in Ethiopia
Completed NCT02763462 - The Etiology of Acute Febrile Illness Requiring Hospitalization
Recruiting NCT05292508 - Comparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood Test N/A
Completed NCT01403350 - Cluster Randomised Trial of Malaria RDTs Used by CHWs in Afghanistan Phase 4
Completed NCT02225769 - Electronic Algorithms Based on Host Biomarkers to Manage Febrile Children N/A
Completed NCT04081051 - Advancing Access to Diagnostic Innovation Essential for UHC and AMR Prevention N/A